The companies - Takeda Pharmaceutical and Daiichi Pharmaceutical - have been subscribers for the last three years. Takeda is now signed on until the end of 2006 and purchased a perpetual license to the data content as of the expiration date of the latest agreement. Daiichi signed up for several more years and will use the system primarily for drug discovery research, with an option to expand to other areas.
Financial terms of the agreements were not disclosed.
Gene Logic's BioExpress consists of genomic and clinical information from a range of normal and pathological human tissues, as well as animal model system tissues and cell lines.